Phase 1 trial: T4 immunotherapy of head and neck cancer

Stuart Hogarth

DNA patents beyond clinical genetics: HPV testing and cervical cancer screening in China, the UK and USA. A comparative investigation of the bioethics of biomarker IP and its implications for public p

Oesophagus Larynx Other pharynx Lip, oral cavity Nasopharynx

Amitabh Chak

Genetic Determinants of Barretts Esophagus and Esophageal Adenocarcinoma

Oesophagus

Pathology

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Nasopharynx Oesophagus

Norman Wolmark

NRG Oncology Network Group Operations Center

Nasopharynx Oesophagus

Radiation Oncology Surgery / Surgical oncology

Shahzadi Ayesha Noorani

Molecular Phenotyping as a novel method of lymph node tracking in oesophageal cancer

Oesophagus

Agata Smogorzewska

The role of nucleases in interstrand crosslink repair

Ovary Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx Corpus uteri Cervix uteri Breast

Jeffrey Nicholas Myers

Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Jeffrey Nicholas Myers

Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Stephen Y Lai

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Radiation Oncology